Mehra MR, Netuka I, Uriel N, Katz JN, Pagani FD, Jorde UP, ARIES-HM3 Investigators, et al. Aspirin and Hemocompatibility Events With a Left Ventricular Assist Device in Advanced Heart Failure: The ARIES-HM3 Randomized Clinical Trial. JAMA. 2023;330(22):2171–81. https://doi.org/10.1001/jama.2023.23204.
Article CAS PubMed PubMed Central Google Scholar
Nascimbene A, Bark D, Smadja DM. Hemocompatibility and biophysical interface of left ventricular assist devices and total artificial hearts. Blood. 2024;143(8):661–72. https://doi.org/10.1182/blood.2022018096.
Article CAS PubMed Google Scholar
Roka-Moiia Y, Miller-Gutierrez S, Palomares DE, Italiano JE, Sheriff J, Bluestein D, Slepian MJ. Platelet Dysfunction During Mechanical Circulatory Support: Elevated Shear Stress Promotes Downregulation of αIIbβ3 and GPIb via Microparticle Shedding Decreasing Platelet Aggregability. Arterioscler Thromb Vasc Biol. 2021;41(4):1319–36. https://doi.org/10.1161/ATVBAHA.120.315583.
Article CAS PubMed PubMed Central Google Scholar
Klaeske K, Dieterlen MT, Eifert S, Scholz U, Garbade J, Jawad K, Sieg F, Borger MA, Meyer AL. Device-induced platelet dysfunction in patients after left ventricular assist device implantation. J Thromb Haemost. 2021;19(5):1331–41. https://doi.org/10.1111/jth.15279.
Article CAS PubMed Google Scholar
Lombardi M, Bonora M, Baldetti L, Pieri M, Scandroglio AM, Landoni G, Zangrillo A, Foglieni C, Consolo F. Left ventricular assist devices promote changes in the expression levels of platelet microRNAs. Front Cardiovasc Med. 2023;10:1178556. https://doi.org/10.3389/fcvm.2023.1178556.
Article CAS PubMed PubMed Central Google Scholar
Zhang YY, Zhou X, Ji WJ, Shi R, Lu RY, Li JL, Yang GH, Luo T, Zhang JQ, Zhao JH, Jiang TM, Li YM. Decreased circulating microRNA-223 level predicts high on-treatment platelet reactivity in patients with troponin-negative non-ST elevation acute coronary syndrome. J Thromb Thrombolysis. 2014;38(1):65–72. https://doi.org/10.1007/s11239-013-1022-9.
Article CAS PubMed Google Scholar
Chyrchel B, Totoń-Żurańska J, Kruszelnicka O, Chyrchel M, Mielecki W, Kołton-Wróż M, Wołkow P, Surdacki A. Association of plasma miR-223 and platelet reactivity in patients with coronary artery disease on dual antiplatelet therapy: A preliminary report. Platelets. 2015;26(6):593–7. https://doi.org/10.3109/09537104.2014.974527.
Article CAS PubMed Google Scholar
Zapilko V, Fish RJ, Garcia A, Reny JL, Dunoyer-Geindre S, Lecompte T, Neerman-Arbez M, Fontana P. MicroRNA-126 is a regulator of platelet-supported thrombin generation. Platelets. 2020;31(6):746–55. https://doi.org/10.1080/09537104.2020.1775804.
Article CAS PubMed Google Scholar
de Boer HC, van Solingen C, Prins J, Duijs JM, Huisman MV, Rabelink TJ, van Zonneveld AJ. Aspirin treatment hampers the use of plasma microRNA-126 as a biomarker for the progression of vascular disease. Eur Heart J. 2013;34(44):3451–7. https://doi.org/10.1093/eurheartj/eht007.
Article CAS PubMed Google Scholar
Jankowska KI, Sauna ZE, Atreya CD. Role of microRNAs in Hemophilia and Thrombosis in Humans. Int J Mol Sci. 2020;21(10):3598. https://doi.org/10.3390/ijms21103598.
Article CAS PubMed PubMed Central Google Scholar
Nourse J, Braun J, Lackner K, Hüttelmaier S, Danckwardt S. Large-scale identification of functional microRNA targeting reveals cooperative regulation of the hemostatic system. J Thromb Haemost. 2018;16(11):2233–45. https://doi.org/10.1111/jth.14290.
Article CAS PubMed Google Scholar
INTERMACS Adverse Events Definitions. STS INTERMACS database. Available at: https://intermacs.kirso.net/intermacs-documents/. Accessed February 19, 2025.
Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, ACC/AHA Joint Committee Members, et al. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022;145(18):e895–1032. https://doi.org/10.1161/CIR.0000000000001063.
Ramani R, Vela D, Segura A, McNamara D, Lemster B, Samarendra V, Kormos R, Toyoda Y, Bermudez C, Frazier OH, Moravec CS, Gorcsan J 3rd, Taegtmeyer H, McTiernan CF. A micro-ribonucleic acid signature associated with recovery from assist device support in 2 groups of patients with severe heart failure. J Am Coll Cardiol. 2011;58(22):2270–8. https://doi.org/10.1016/j.jacc.2011.08.041.
Article PubMed PubMed Central Google Scholar
Morley-Smith AC, Mills A, Jacobs S, Meyns B, Rega F, Simon AR, Pepper JR, Lyon AR, Thum T. Circulating microRNAs for predicting and monitoring response to mechanical circulatory support from a left ventricular assist device. Eur J Heart Fail. 2014;16(8):871–9. https://doi.org/10.1002/ejhf.116.
Article CAS PubMed Google Scholar
Barsanti C, Trivella MG, D’Aurizio R, El Baroudi M, Baumgart M, Groth M, Caruso R, Verde A, Botta L, Cozzi L, Pitto L. Differential regulation of microRNAs in end-stage failing hearts is associated with left ventricular assist device unloading. Biomed Res Int. 2015;2015:592512. https://doi.org/10.1155/2015/592512.
Article CAS PubMed PubMed Central Google Scholar
Landry P, Plante I, Ouellet DL, Perron MP, Rousseau G, Provost P. Existence of a microRNA pathway in anucleate platelets. Nat Struct Mol Biol. 2009;16(9):961–6. https://doi.org/10.1038/nsmb.1651.
Article CAS PubMed PubMed Central Google Scholar
Zhang LJ, Hu YX, Huang RZ, Xu YY, Dong SH, Guo FH, Guo JJ, Qiu JJ, Cao ZY, Wei LJ, Mao JH, Lyu A, Liu JL, Zhao XX, Guo ZF, Jing Q. Intraplatelet miRNA-126 regulates thrombosis and its reduction contributes to platelet inhibition. Cardiovasc Res. 2024;120(13):1622–35. https://doi.org/10.1093/cvr/cvae138.
Article CAS PubMed Google Scholar
Krammer TL, Mayr M, Hackl M. microRNAs as promising biomarkers of platelet activity in antiplatelet therapy monitoring. Int J Mol Sci. 2020;21(10):3477. https://doi.org/10.3390/ijms21103477.
Article CAS PubMed PubMed Central Google Scholar
Jury D, Daugaard I, Sanders KJ, Hansen LL, Agalliu D, Pedersen IM. miR-151a enhances Slug dependent angiogenesis. Oncotarget. 2020;11(23):2160–71. https://doi.org/10.18632/oncotarget.27331.
Article PubMed PubMed Central Google Scholar
Cannavicci A, Zhang Q, Kutryk MJB. The Potential Role of MiRs-139-5p and -454-3p in Endoglin-Knockdown-Induced Angiogenic Dysfunction in HUVECs. Int J Mol Sci. 2023;24(5):4916. https://doi.org/10.3390/ijms24054916.
Article CAS PubMed PubMed Central Google Scholar
Lim S, Chue CD, Ranasinghe A, Mascaro JG. Discontinuation of Aspirin in HeartMate 3: Long-Term Outcomes. J Heart Lung Transplant. 2020;39(4S):S48.
Consolo F, Pozzi L, Pieri M, Della Valle P, Redaelli A, D’Angelo A, Pappalardo F. Influence of Different Antithrombotic Regimens on Platelet-Mediated Thrombin Generation in Patients with Left Ventricular Assist Devices. ASAIO J. 2020;66(4):415–22. https://doi.org/10.1097/MAT.0000000000001064.
Consolo F, Raimondi Lucchetti M, Tramontin C, Lapenna E, Pappalardo F. Do we need aspirin in HeartMate 3 patients? Eur J Heart Fail. 2019;21(6):815–7. https://doi.org/10.1002/ejhf.1468.
Saeed O, Colombo PC, Mehra MR, Uriel N, Goldstein DJ, Cleveland J, Connors JM, Najjar SS, Mokadam NA, Bansal A, Crandall DL, Sood P, Jorde UP. Effect of aspirin dose on hemocompatibility-related outcomes with a magnetically levitated left ventricular assist device: An analysis from the MOMENTUM 3 study. J Heart Lung Transplant. 2020;39(6):518–25. https://doi.org/10.1016/j.healun.2020.03.001.
Article PubMed PubMed Central Google Scholar
Gustafsson F. Is aspirin needed to prevent thrombotic events in patients treated with a HeartMate 3 left ventricular assist device? J Heart Lung Transplant. 2020;39(6):526–8. https://doi.org/10.1016/j.healun.2020.03.019.
Marshall D, Sanchez J, Yuzefpolskaya M, Sayer GT, Takeda K, Naka Y, Colombo PC, Uriel N, Topkara VK. Safety of reduced anti-thrombotic strategy in patients with HeartMate 3 left ventricular assist device. J Heart Lung Transplant. 2021;40(4):237–40. https://doi.org/10.1016/j.healun.2021.01.012.
Comments (0)